Company intelligence / Profile preview

Noor ul Ain

Lahore, Punjab, Pakistan

Ownership: Private
Development stage: Other

Overview

Noorulain Pharmaceuticals is a Pakistan-based pharmaceutical company focused on the manufacturing and marketing of a wide range of generic therapeutic products. The company operates a manufacturing facility that produces various dosage forms, including tablets, capsules, syrups, and dry suspensions. Its product portfolio spans multiple therapeutic areas such as anti-infectives, analgesics, and gastrointestinal treatments, catering primarily to the domestic market in Pakistan. Noorulain Pharmaceuticals emphasizes quality compliance and affordable healthcare solutions within the regional pharmaceutical landscape.

Therapeutic areas: Infectious DiseasesPulmonologyNeurologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Noor ul Ain.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noor ul Ain.

Explore the full profile